Breast Biopsy Device Market 2019 Industry Size , Share ,Development Strategy, Emerging Opportunities, Sales Revenue, Comprehensive Research Study, Competitive Landscape and Trends by Forecast 2026

Breast biopsy is the procedure done to obtain tissues or cell samples from the breast. The sample obtained is further tested to check for the presence of cancer. There are 3 types of biopsies, namely core-needle biopsy, fine-needle biopsy, and surgical biopsy.



The major factors that are driving the growth of the
Breast Biopsy Devices Market are the rising incidence of breast cancer, rising number of breast cancer screening programs across the globe, and increasing reimbursement rates in developed countries and market is growing at a CAGR of approximately 10.9%.



The major players in this market are increasingly focusing on launching new and technological advanced products. This is also expected to drive market growth. The breast biopsy wounds and cuts are susceptible to infections if proper care is not taken. This factor may impede the growth of the breast biopsy devices market.



Request for a sample @
https://www.alltheresearch.com/sample-request/26



Top Key Players

The major players operating in the global breast biopsy devices market are C.R. Bard Inc (US), Hologic Inc. (US), Argon Medical Devices (US), Beckton Dickinson (US), Cook Medical Inc. (US), Ethicon Endo Surgery (Johnson & Johnson) (US), Devicor Medical Products (US), Encapsule Medical Devices LLC (US), and Intact Medical Corporation (US), amongst others.



The breast biopsy devices market has been segmented into, needle-based biopsy guns, biopsy needles, and guidance systems and others.

The guidance systems segment is further divided into Ultrasound-guided, Mammography equipment, and Magnetic Resonance.
The biopsy needle segment is further segmented into, disposable biopsy needles and reusable biopsy needles.
The needle-based biopsy guns segment is further segmented into Fine needle aspiration biopsy devices, vacuum-assisted biopsy devices, and Core needle biopsy devices.
The other devices include, biopsy tables, localization wires, and biopsy forceps, amongst others.


Speak to Our Expert @
https://www.alltheresearch.com/speak-to-analyst/26



Geographically, North America is dominating the breast biopsy devices market. The major factors responsible for the dominance of this region are the increasing incidence of breast cancer and rising screening programmes in the region. For instance, according the International Agency for Research on Cancer, the number of new breast cancer cases in the US was 234,087 in the year 2018.



The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The rising incidence of breast cancer in countries such as Japan, China, and India is one of the major factors in driving the growth of the breast biopsy devices market in this region.



Key Questions answered:

What is the value of the overall breast biopsy devices market and its segments?

What is the market value at the regional and individual country level?

What are the attractive segments and geographies to invest in?

What are the key drivers, restraints, opportunities, and challenges in the market and how are they expected to impact the market?

What are the macroeconomic indicators impacting the country's dynamics?

Who are the key market players and their key competitors?

Who are the major players present in each region and their key strategies?

How are the breast biopsy device market players positioned with respect to their business strength and product portfolio?



Get a Customization as per Requirements @
https://www.alltheresearch.com/customization/26

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:

Email:
contactus@alltheresearch.com

Phone: 1-888-691-6870

Address: 39180 Liberty Street Suite 110, Fremont, CA 94538, USA

ABOUT ALLTHERESEARCH:

AllTheResearch was formed with the aim of making market research a significant tool for managing breakthroughs in the industry. As a leading market research provider, the firm empowers its global clients with business-critical research solutions. The outcome of our study of numerous companies that rely on market research and consulting data for their decision-making made us realise, that it’s not just sheer data-points, but the right analysis that creates a difference.

This release was published on openPR.